Sort
15,842 grants matching “pancreatic cancer”
Discovery of Risk Loci and Genomics of Pancreatic Cancer through Exome Sequencing
$1,100,589Paul A Scheet · University Of Tx Md Anderson Can Ctr · R01 · FY2014 · CA
Translational Research in GI Cancer
$1,100,000Dean E. Brenner · University Of Michigan At Ann Arbor · P50 · FY2016 · CA
Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer
$1,099,737Ajay Goel · Beckman Research Institute/City Of Hope · U01 · FY2019 · CA
Rewired Signaling at the Nexus of Melanoma Metastasis and Resistance
$1,099,568Ze'ev A Ronai · Sanford Burnham Prebys Medical Discovery Institute · R35 · FY2019 · CA
Metal Chelate Conjugated Monoclonal Antibodies for Tumor Diagnosis and Therapy
$1,099,106Martin W Brechbiel · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
A Patient-Centric Approach to Advance Functional Precision Oncology
$1,098,796Christopher J Kemp · Fred Hutchinson Cancer Center · U01 · FY2023 · CA
Signal Transduction Events and the Regulation of Cell Growth
$1,097,545Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2020 · CA
Computational Tools For Bioinformatics And Genome Analysis
$1,097,447John I Powell · Center For Information Technology · ZIA · FY2015 · CT
Histidine phosphorylation as a new target for cancer therapy
$1,096,680Tony R. Hunter · Salk Institute For Biological Studies · R35 · FY2024 · CA
Heritable Neurodegenerative and Autoimmune Disorders
$1,095,625Anil B Mukherjee · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2009 · HD
CEACAM5-targeted activation of potent chemotherapeutics via bioorthogonal click chemistry
$1,094,189Jose M Mejia Oneto · Shasqi, Inc. · R44 · FY2025 · CA
Development of Monoclonal Antibodies to Treat Pancreatic Cancer
$1,094,011Sripathi M Sureban · Coare Biotechnology, Inc. · R44 · FY2017 · CA
Time Domian Electron Paramagnetic Resonance Imaging
$1,093,343Murali Krishna · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Great Lakes/New England Clinical Epidemiology/Validation
$1,091,808Dean E. Brenner · University Of Michigan At Ann Arbor · U01 · FY2007 · CA
PNNL Proteome Characterization Center
$1,091,415Tao Liu · Battelle Pacific Northwest Laboratories · U24 · FY2017 · CA
Preclinical drug development in pancreatic cancer
$1,089,780Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Functional Genomics of Sarcoma
$1,089,700Paul S. Meltzer · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Gene expression and regulation in endocrine cancers
$1,088,656Electron Kebebew · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
RaceCAR-M immunotherapy for cancer and beyond
$1,088,500Denise J. Montell · University Of California Santa Barbara · DP1 · FY2024 · CA
RaceCAR-M immunotherapy for cancer and beyond
$1,088,500Denise J. Montell · University Of California Santa Barbara · DP1 · FY2025 · CA
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma
$1,088,453Guido Erwin Michael Eibl · University Of California Los Angeles · P01 · FY2024 · CA
Modulation of Therapeutic Response
$1,088,014James Mitchell · Division Of Clinical Sciences - Nci · ZIA · FY2017 · CA
Signal Transduction Events and the Regulation of Cell Growth
$1,085,526Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2023 · CA
Xenobiotic metabolism, cancer chemoprevention and cancer biomarkers
$1,083,650Frank J Gonzalez · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Generation of antibody-drug conjugates by proximity-based sortase-mediated ligation
$1,081,188Feifan Yu · Alphathera, Inc. · R44 · FY2021 · CA